Brief: Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
03/03/2026 21:20
March 3 (Reuters) - Arbutus Biopharma Corp ABUS.O: GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2.25 BILLION GLOBAL SETTLEMENT WITH MODERNA ROIVANT SCIENCES - ARBUTUS IS CURRENTLY EVALUATING A RETURN OF CAPITAL TO SHAREHOLDERS FOR Q3 OF CALENDAR YEAR 2026 Source text: ID:nGNX7ZNTnK Further company coverage: ABUS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare